Philipp Boehringer (#607)
- $ 7 B
- Pharmaceuticals
- Germany
- M
- 47 Years
'A form of double taxation': Are management fees on new houses quietly getting out of control?
Trump Official Blames Biden Admin for Economic ‘Mess’ — As Resurfaced Clip Shows Him Saying Trump Would Own the Economy By 2026
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is Transocean Ltd. (RIG) A Good Stock To Buy Now?
Tesla is selling Chinese-made cars in Canada to escape the tariffs that both China and America imposed on it
Insecurity didn’t start with Tinubu, group defends president’s security record
Vibrating pillow sleeve warns deaf sleepers of burglars and fires
How Kepler built verifiable AI for financial services with Claude
Is ASML Holding N.V. (ASML) A Good Stock To Buy Now?
5-Letter Words Ending in ‘Y’ to Help You Improve Your Wordle Skills
About Me
Philipp Boehringer's fortune is derived from Boehringer Ingelheim, the world's largest private player in the pharmaceutical industry. Founded in 1885 by Albert Boehringer, the company sold ingredients to pharmacies, textile merchants and the food industry, and grew to a workforce of 1,500 by the time of his death. Today Boehringer Ingelheim employs 53,000 people and has a presence in 130 markets. Some of its most well-known drugs treat COPD, anti-coagulation and type 2 diabetes. Philipp along with 14 members of the family -- all in the third, fourth or fifth generation, own equal parts of the company.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Philipp Boehringer’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Philipp Boehringer’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $6.6B
(May 4, 2026)
© Iconic Billionaires